AGGREGATION EFFICIENCY OF ACTIVATED NORMAL OR FIXED PLATELETS IN A SIMPLE SHEAR FIELD - EFFECT OF SHEAR END FIBRINOGEN OCCUPANCY

被引:41
作者
XIA, ZM [1 ]
FROJMOVIC, MM [1 ]
机构
[1] MCGILL UNIV, DEPT PHYSIOL, MONTREAL H3G 1Y6, PQ, CANADA
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0006-3495(94)81015-X
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Shear rate can affect protein adsorption and platelet aggregation by regulating both the collision frequency and the capture efficiency (alpha). These effects were evaluated in well defined shear field in a micro-couette for shear rate G = 10-1000 s(-1). The rate of protein binding was independent of G, shown for adsorption of albumin to latex beads and PAC1 to activated platelets. The initial aggregation rate for ADP-activated platelets in citrated platelet-rich plasma followed second order kinetics at the initial platelet concentrations between 20,000 and 60,000/mu l. alpha values, which dropped nearly fivefold for a 10-fold increase in G, were approximately proportional to G(-1), contrary to a minor drop predicted by the theory that includes protein cross-bridging. Varying ADP concentration did not change a of maximally activated platelet subpopulations, suggesting that aggregation between unactivated and activated platelets is negligible. Directly blocking the unoccupied but activated GPIIb-IIIa receptors without affecting pre-bound Fg on ''RGD''-activated, fixed platelets (AFP) by GRGDSP or Ro 43-5054 eliminated aggregation, suggesting that cross-bridging of GPllb-llla on adjacent platelets by fibrinogen mediates aggregation. a for AFP remained maximal (similar to 0.24) over 25-75% Fg occupancy, otherwise decreasing rapidly, with a half-maximum occurring at around 2% occupancy, suggesting that very few bound Fg were required to cause significant aggregation.
引用
收藏
页码:2190 / 2201
页数:12
相关论文
共 56 条
[31]   A METHOD FOR QUANTITATING PLATELET-AGGREGATION AND ANALYZING DRUG-RECEPTOR INTERACTIONS ON PLATELETS IN WHOLE-BLOOD INVITRO [J].
LUMLEY, P ;
HUMPHREY, PPA .
JOURNAL OF PHARMACOLOGICAL METHODS, 1981, 6 (02) :153-166
[32]  
MARGUERIE GA, 1980, J BIOL CHEM, V255, P154
[33]  
Milnor W. R., 1982, HEMODYNAMICS
[34]   FIBRINOGEN INTERACTION WITH PLATELET RECEPTORS [J].
NIEWIAROWSKI, S ;
KORNECKI, E ;
BUDZYNSKI, AZ ;
MORINELLI, TA ;
TUSZYNSKI, GP .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1983, 408 (JUN) :536-555
[35]  
PEDVIS LG, 1988, THROMB HAEMOSTASIS, V59, P323
[36]  
PEERSCHKE EI, 1981, BLOOD, V57, P663
[37]  
PEERSCHKE EIB, 1985, SEMIN HEMATOL, V22, P241
[38]  
PETERSON DM, 1987, BLOOD, V69, P625
[39]  
PLOW EF, 1989, PROG HEMOST THROMB, V9, P117
[40]   INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY THE TETRAPEPTIDE "GLYCYL-L-PROLYL-L-ARGINYL-L-PROLINE [J].
PLOW, EF ;
MARGUERIE, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (12) :3711-3715